Curaleaf (OTCMKTS:CURLF) Announces Earnings Results

Curaleaf (OTCMKTS:CURLF) issued its quarterly earnings data on Wednesday. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.01), reports. The business had revenue of $330.53 million during the quarter, compared to analyst estimates of $345.83 million. Curaleaf had a negative net margin of 18.59% and a negative return on equity of 14.75%.

Curaleaf Price Performance

Shares of OTCMKTS CURLF traded up $0.08 during mid-day trading on Friday, reaching $2.25. The company’s stock had a trading volume of 2,221,750 shares, compared to its average volume of 689,210. The stock has a 50-day moving average of $2.99 and a two-hundred day moving average of $3.82. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.50 and a current ratio of 1.09. The stock has a market capitalization of $1.46 billion, a P/E ratio of -6.44 and a beta of 0.86. Curaleaf has a 1-year low of $2.07 and a 1-year high of $6.40.

Wall Street Analyst Weigh In

CURLF has been the topic of a number of research analyst reports. Cormark cut shares of Curaleaf from a “moderate buy” rating to a “hold” rating in a research note on Thursday. Needham & Company LLC reissued a “buy” rating and set a $6.25 target price on shares of Curaleaf in a research note on Thursday, August 8th.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.